PF-05105679

Generic Name: PF-05105679

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₆H_₂₁FN_₂O_₃

CAS Number: 1398583-31-7

Unique Ingredient Identifier: F2B10OFV7Y

Background: PF-05105679 is under investigation in clinical trial NCT01393652 (Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Mechanism of Human Cold Pain Perception - Involvement of TRPA1, TRPM8, Nav1.7 and Nav1.8

Early Phase 1

Completed

Conditions: Pain

Interventions: Other: Room temperature
Other: Cold temperature
Drug: PF-06305591
Drug: Lidocain
Drug: A967079
Drug: PF-05105679
Drug: PF-05089771

First Posted Date: 2023-07-07

Last Posted Date: 2024-03-15

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 36

Registration Number: NCT05935280

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Single Dose, Dose Escalation Healthy Volunteers Study Of PF-05105679

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: PF-05105679

First Posted Date: 2011-07-13

Last Posted Date: 2011-10-03

Lead Sponsor: Pfizer

Target Recruit Count: 32

Registration Number: NCT01393652

Locations: 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy